One Turn
India cuts prices of 137 cancer drugs after Supreme Court case
India's government moved to reduce prices of 137 cancer drugs from next month after the Supreme Court ruled that mark-ups amounted to 'extortion'. The case was filed in 2022 by a retired bank clerk who could not afford her medicine.
Why it matters
Lower prices could make treatment affordable for millions of patients who face financial ruin from a diagnosis.
Background
Many Indian patients pay for medicine out of pocket. India regulates prices of some essential drugs through a national authority.
The story so far
- India cuts prices of 137 cancer drugs after Supreme Court case
- India cuts prices of 137 cancer drugs
Sources
- The Guardian ↗Oct 23, 3:00 AM ET
This summary was written automatically from the reporting linked above; follow the sources for the full story. How One Turn works.